Association of FOSL1 copy number alteration and triple negative breast tumors
AUTOR(ES)
Serino, Leandro Tamião Rodrigues
FONTE
Genet. Mol. Biol.
DATA DE PUBLICAÇÃO
28/02/2019
RESUMO
Abstract Copy number alterations (CNAs) are a frequent feature in human breast cancer, and one of the hallmarks of genomic instability. The FOSL1, GSTP1 and CCND1 genes are located at 11q13, a cytoband commonly affected by CNA in breast cancer, with relevant function in progression and invasion. Our main goal was to analyze CNAs of these genes and determine their association with breast cancer subtypes. Seventy-three cases of invasive breast tumors [52 Luminal, 7 HER2+ and 14 triple negative (TNBC) subtypes] were analyzed by TaqMan assays. CNAs were observed for all genes, with gains more frequently observed. Gains of the FOSL1 gene were observed in 71% of the cases. This gene was the only one with a statistically significant difference (p<0.001) among tumor subtypes, with increased copy number in TNBC compared to luminal and HER2+. No significant association of CNA and clinical and histopathological parameters from the patients was observed. Additional studies in larger breast cancer patient cohorts based on more refined molecular subtypes are necessary to confirm the observed association of FOSL1 gain with aggressive breast tumors phenotypes.
Documentos Relacionados
- Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors
- Quantitative analysis of chromosomal CGH in human breast tumors associates copy number abnormalities with p53 status and patient survival
- Origin pairing (‘handcuffing’) as a mode of negative control of P1 plasmid copy number
- Comparative analyses of gene copy number and mRNA expression in glioblastoma multiforme tumors and xenografts
- Characterization and complementation of pMB1 copy number mutant: effect of RNA I gene dosage on plasmid copy number and incompatibility.